SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001477932-23-000086
Filing Date
2023-01-04
Accepted
2023-01-04 16:15:14
Documents
1
Period of Report
2022-12-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 4099
  Complete submission text file 0001477932-23-000086.txt   5657
Mailing Address C/O INNOVATION PHARMACEUTICALS INC. 301 EDGEWATER PLACE - SUITE 100 WAKEFIELD MA 01880
Business Address
EHRLICH LEO (Reporting) CIK: 0001288099 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37357 | Film No.: 23506546

Mailing Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880
Business Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880 978-921-4125
Innovation Pharmaceuticals Inc. (Issuer) CIK: 0001355250 (see all company filings)

IRS No.: 300565645 | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations